FDA Import Refusal BUU-1813676-8/10002/1 — Nanjing Chengong Pharmaceutical Co., Ltd.
The FDA refused shipment BUU-1813676-8/10002/1 from Nanjing Chengong Pharmaceutical Co., Ltd. (China) on Jun 8, 2026. The refused product falls under Drugs and Biologics — ORFORGLIPRON (ANTI-DIABETIC). Cited charge: 27 This firm has 3 other import refusals on record.
Refusal details
- Date
- Jun 8, 2026
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61PAY77 ORFORGLIPRON (ANTI-DIABETIC)
- Charges
- 27